News

6th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner

April 11, 2024 Read Article

New CEVR Publication: It's time to reconsider the three percent discount rate.

March 19, 2024 Read Article

Despite criticisms of Accelerated Approval pathway—commercial payers defer to FDA

March 14, 2024 Read Article

New CEVR publication: Are We Valuing Prescription Drugs Appropriately?

February 5, 2024 Read Article

Are models used in cost-effectiveness analyses “open-source”? A Survey of CEA Authors

January 18, 2024 Read Article

2024 CEA Registry Remote Summer Fellowship

January 9, 2024 Read Article

Season's greetings from Tufts CEVR!

December 21, 2023 Read Article

How might US health plans cover gene therapies for Sickle Cell Disease? Insights from the SPEC Database

December 13, 2023 Read Article

The Best Books I Read in 2023

December 5, 2023 Read Article

CEVR Appoints New Experts to CEA Registry Scientific Advisory Board and Discusses Priorities for 2024

October 30, 2023 Read Article